Related Experiment Video
Updated: Aug 15, 2026

A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
Retrograde pulmonary embolectomy in massive pulmonary embolism
Khalil Zarrabi1, Hooman Yarmohammadi, Mohammad Ali Ostovan
1Division of Cardiothoracic Surgery, Department of Surgery, Namazee Hospital, Shiraz University of Medical Sciences, Zand Ave., P.O. Box 71345-1876, Shiraz, Iran. yarmohml@sums.ac.ir
This study introduces retrograde thromboembolectomy for acute massive pulmonary emboli, showing a potentially safer alternative with fewer adverse effects. Further large-scale studies are needed to confirm its efficacy and safety as a new technique.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Pulmonary Medicine
Background:
- Acute massive pulmonary embolism is a life-threatening condition.
- Current treatment options carry significant risks.
- There is a need for safer and effective interventions.
Observation:
- A 56-year-old female patient presented with acute massive pulmonary thromboemboli.
- The study introduced and evaluated the efficacy and safety of retrograde thromboembolectomy.
- The patient experienced an uneventful postoperative course following the procedure.
Findings:
- Retrograde thromboembolectomy demonstrated efficacy in managing acute massive pulmonary thromboemboli.
- The surgical technique appears to be associated with fewer adverse effects compared to existing methods.
- The procedure was technically feasible in the described case.
Implications:
- Retrograde thromboembolectomy may offer a valuable alternative treatment option for acute massive pulmonary embolism.
- This technique could potentially reduce morbidity and mortality associated with pulmonary embolism.
- Further extensive research and clinical trials are warranted to establish its widespread adoption and safety profile.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
Pneumothorax-II
Clinical Manifestations:
